Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Name: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
Published: 2026
License: Public Domain

Tianjin Huanhu Hospital · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

multiple-sclerosis

neuromyelitis optica spectrum disorders, multiple sclerosis, myasthenia gravis, universal allogeneic car t-cells, qt-019c, interventional, early_phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Related documents